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Aspergillus fumigatus, an opportunistic fungal pathogen, causes multiple allergic and non-
allergic airway diseases. Invasive pulmonary aspergillosis (IPA) is a nonallergic, life-threat-
ening disease of immunocompromised patients. In a murine model of IPA, interleukin
(IL)–4–deficient (IL-42/2) BALB/c mice were used to examine the role of IL-4 in lung pathology
and immune responses. IL-42/2 mice were more resistant than wild-type mice to infection
caused by multiple intranasal injections of viable A. fumigatus conidia. Resistance was as-
sociated with decreased lung inflammatory pathology, impaired T helper (Th)–2 responses
(including lung eosinophilia), and an IL-12–dependent Th1 response. In contrast, development
of host-detrimental antifungal Th2 cells occurred in IL-122/2 and interferon-g2/2 mice and in
IL-42/2 mice when subjected to IL-12 neutralization. These results demonstrate that IL-4
renders mice susceptible to infection with A. fumigatus by inhibition of protective Th1 re-
sponses. IL-4 appears to have a distinct role in the pathogenesis of allergic and nonallergic
lung diseases caused by the fungus.
Aspergillus fumigatus is a ubiquitous and opportunistic fun-
gal pathogen of humans and animals. It is associated with a
wide spectrum of diseases, ranging from benign colonization
of the lung and allergies to life-threatening diseases such as
invasive pulmonary aspergillosis (IPA) or allergic bronchopul-
monary aspergillosis (ABPA) [1]. A variety of underlying
conditions, including impaired immune status, contribute to
development of aspergillosis [2]. In moderately immunocom-
promised persons, a chronic necrotizing aspergillosis may be a
discrete clinical entity [3]. However, among immunocompro-
mised persons, IPA, characterized by hyphal invasion and de-
struction of pulmonary tissue, is the most common manifes-
tation of Aspergillus infection [1, 4]. It has been suggested that
cells of the innate immune system may play an important role
in the defense against IPA [5]. Resident alveolar macrophages
ingest and kill resting conidia, largely through nonoxidative
mechanisms, while neutrophils use oxygen-dependent mecha-
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nisms to attack hyphae germinating from conidia that escape
macrophage surveillance [6]. Major recognized risk factors for
disease are defects in phagocyte respiratory burst, such as those
occurring in chronic granulomatous disease [7, 8]; cortisone-
induced suppression of macrophage conidiocidal activity [9, 10],
and neutropenia [11]. Increased risk for a chronic form of IPA,
which is independent of neutropenia and corticosteroid therapy,
has been observed in persons infected with human immuno-
deficiency virus [12], who also showed a defective effector ac-
tivity of neutrophils against A. fumigatus [13].
More recent evidence in humans indicates that a dysregulated
production of T helper (Th) cell cytokines may contribute to
the pathogenesis of IPA [14–16]. In a murine model of IPA, we
showed that production of Th1 and Th2 cytokines differed in
mice resistant or susceptible to the infection [17]. Resistance to
infection and development of protective immunity were asso-
ciated with high levels of tumor necrosis factor (TNF)–a and
interleukin (IL)–12, an efficient innate antifungal effector func-
tion, and with detection of interstitial lung lymphocytes pro-
ducing interferon (IFN)–g. In contrast, production of IL-4 and
IL-10 by interstitial CD4 Th2 lymphocytes was associated with
disease progression, and local IL-4 or IL-10 neutralization im-
proved the infection [17].
IL-4 is the primary determinant of differentiation of CD4 T
cells into Th2 cytokine-producing cells in fungal infections [18].
In addition to its pivotal role in CD4 T cell differentiation, IL-
4 mediates inflammatory pathology in allergic lung diseases
[19]. Despite substantial evidence for the importance of IL-4
in these diseases, much controversy remains on its specific
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pathogenetic role [20–22]. In the case of exposure to A. fumi-
gatus antigens, a further complication arises from clinical and
experimental findings indicating that both Th2 [23, 24] and Th1
[25, 26] cells contribute to the pathogenesis of the ensuing lung
diseases. To definitively describe the role of IL-4 in the infection
and lung pathogenesis of airway disease caused by the fungus,
we evaluated the course and outcome of IPA, lung pathology,
and parameters of local innate and adaptive Th immunity in
IL-4–deficient (IL-42/2) mice on exposure to A. fumigatus
conidia.
Materials and Methods
Mice. We used female 8–10-week-old inbred DBA/2 (H-2d)
mice (Charles River, Calco, Italy). Breeding pairs of homozygous
IL-42/2, IL-5–deficient (IL-52/2), and IFN-g–deficient (IFN-g2/2),
generated as described elsewhere [27–29], were backcrossed for sev-
eral generations (6 or 7) to BALB/c at the Basel Institute for Im-
munology. Breeding pairs of homozygous IL-12p40–deficient (IL-
12p402/2) and BALB/c wild-type mice were provided by L. Adorini
(Hoffmann-LaRoche, Milan, Italy). Knockout and wild-type con-
trol mice were maintained under specific pathogen-free conditions
in the Medical School of Perugia animal facility. Mice 8–10 weeks
old of both sexes were used.
Microorganism, culture conditions, and infection. The A. fu-
migatus strain, derived from a person who died of pulmonary as-
pergillosis, was obtained at the Infectious Diseases Institute of the
University of Perugia. The microorganism was grown for 4 days
at room temperature on Sabouraud dextrose agar (Difco Labo-
ratories, Detroit) supplemented with chloramphenicol. Abundant
conidia were elaborated under these conditions. Conidia were re-
moved by washing the slant culture with 5 mL of 0.025% Tween
20 in saline and gently scraping the conidia from the mycelium
with a plastic pipette (or by vigorous shaking). Cell debris was
allowed to settle by gravity, and the suspension was decanted into
50-mL plastic conical tubes. After extensive washing of the conidia
with saline, conidia were counted and diluted to the desired con-
centrations. The viability of the conidia was 195%, as determined
by serial dilution and plating of the inoculum on Sabouraud dex-
trose agar. For intranasal (inl) infection, mice were lightly anes-
thetized by inhaled diethyl ether before instillation for 3 consecutive
days with a suspension of conidia/20 mL of saline slowly72 3 10
applied to the nostrils with a micropipette with a sterile disposable
tip. The animals were held upright until the suspension was com-
pletely inhaled and normal breathing resumed [17]. Mice dying of
fungal infection were routinely necropsied for histopathologic con-
firmation of invasive aspergillosis. For histology, tissues were ex-
cised and immediately fixed in formalin. Sections (3–4 mm) of par-
affin-embedded tissues were stained by periodic acid–Schiff or
Giemsa.
Chitin assay. For the quantification of fungal growth in the
organs, we used the chitin assay as described elsewhere [17, 30].
Results are expressed as micrograms of glucosamine/organ. Positive
control included serially diluted D(1)-glucosamine (Sigma, St.
Louis). The glucosamine content of lungs from uninfected mice
was used as negative control; this ranged from 0.80 to 2.25 mg of
glucosamine/organ.
Collection of bronchoalveolar lavage (BAL) fluid. Lungs were
lavaged thoroughly with 0.5 mL of PBS injected via the trachea,
as described elsewhere [17]. The lavage fluid was centrifuged, and
the supernatant was removed and immediately stored at 2807C
until analyzed for cytokine and IgE contents.
In vivo treatments. For immunosuppression, mice were injected
intraperitoneally (ip) with 150 mg/kg of cyclophosphamide (Sigma)
3 days before challenge. For B7-1 and B7-2 blockade in vivo, mice
were given inl 100 mg of affinity-purified hamster anti-mouse B7-
1 (clone 16-10A1) [31] and/or rat anti-mouse B7-2 (clone GL1) [32]
in 50 mL of saline 4 h before fungal challenge. Control animals
were administered 100 mg of hamster IgG (Zymed Laboratories,
South San Francisco) or the isotype-matched rat IgG2a (GL117).
Polyclonal sheep anti–IL-12 antibodies (Genetics Institute, Cam-
bridge, MA) or control antibodies (Zymed) were given ip (500 mg)
4 h before the fungal inoculation. Endotoxin was removed from
all solutions with Detoxi-gel (Pierce Chemical, Rockford, IL).
Isolation, phenotypic analysis, and cell culture. Interstitial lung
lymphocytes were isolated as described elsewhere [17]. The pul-
monary vasculature was perfused with 5 mL of PBS containing
100 U/mL heparin to eliminate peripheral blood cells, and the lungs
were removed, minced, and incubated for 90 min at 377C in di-
gestion buffer containing 0.7 mg/mL collagenase (Sigma) and 30
mg/mL type IV bovine pancreatic DNase I (Sigma). Large partic-
ulate matter was removed by passing the cell suspension through
a small, loose, nylon wool plug, and lymphocytes were enriched
over a single-step ficoll gradient. Flow cytometric analysis of lung
T cells revealed that interstitial lymphocytes consisted of abTCR-
bearing CD3 cells (62% and 55% in mutant and wild-type mice,
respectively); gdTCR-bearing CD3 cells (11% and 9%); B2201 cells
(27% and 25%); CD31CD4high (8% and 8%), CD31CD45RBlow (23%
and 33%), and CD31CD281 cells (21% and 17%). Cells were re-
suspended in RPMI containing 10% fetal calf serum, 2-mercap-
toethanol (50 mM), sodium pyruvate (1 mM), HEPES (10 mM),
and gentamycin (50 mg/mL) and were plated at a concentration of
in 96-well microtiter plates coated with 12 mg/mL hamster52 3 10
anti-mouse CD3 monoclonal antibody (MAb; clone 145-2C11;
PharMingen, San Diego). After 48 h of culture, supernatants were
removed, and cytokine production was determined by specific
ELISAs. Purified lung macrophages and neutrophils were obtained
by 2-h plastic adherence or by positive selection with the anti-
granulocyte MAb RB6-8C5, respectively, as described elsewhere
[17, 33].
Cytokine and IgE assays. The levels of IFN-g, IL-4, IL-5, and
IL-10 in culture supernatants of activated cells were determined by
cytokine-specific ELISAs using pairs of anti-cytokine MAbs, as
described elsewhere [17, 30]. The antibody pairs used were as fol-
lows, listed by capture/biotinylated detection: IFN-g, R4-6A2/
XMG1.2; IL-4, BVD4-1D11/BVD6-24G2; IL-5, TRFK-5/TRFK-
4; IL-10, JES5-2A5/SXC-1 (PharMingen). For IL-12p70 measure-
ment, a modified antibody capture bioassay was used [17, 30].
Cytokine titers were calculated by reference to standard curves
constructed with known amounts of recombinant cytokines from
PharMingen, except IL-12, which was from Genetics Institute. A
micro-ELISA procedure was used to quantitate total IgE in the
BAL fluid [17]. Each sample was assayed in triplicate >3 times.
Hyphal damage and conidiocidal assays. A colorimetric MTT
assay [17] was used to study Aspergillus hyphal damage by lung
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Table 1. Course and outcome of invasive pulmonary aspergillosis in
interleukin (IL)–42/2 and IL-52/2 mice.
Group Cyclophosphamidea Mice
Infectionb Chitin contentc
MST D/T 1 day 7 days
1 2 IL-42/2 160 0/8 9.24d 0.80d
2 2 IL-41/1 160 0/10 16.72 3.31
3 1 IL-42/2 160e 2/8 12.40d 7.45
4 1 IL-41/1 8 10/10 28.44 )
5 1 IL-52/2 9 8/8 32.42 )
6 1 IL-51/1 8 10/10 31.76 )
7 2 DBA/2 160 1/8 18.65 4.21
8 1 DBA/2 5 8/8 34.51 )
NOTE. IL-42/2, IL-4 deficient; IL-41/1, IL-4 nondeficient; IL-52/2, IL-5 de-
ficient; IL-51/1, IL-5 nondeficient; MST, median survival time (days); D/T, no.
of dead mice over total no. of mice infected.
a Cyclophosphamide (150 mg/kg) was given intraperitoneally the day before
first intranasal (inl) challenge. Minus sign (2), not treated; plus sign (1), treated.
b Mice were injected inl with conidia of Aspergillus fumigatus on days72 3 10
0 and 1 and 2 days later.
c Chitin content in lungs, expressed as mg of glucosamine/organ, was deter-
mined 1 and 7 days after last fungal inl inoculation (values are mean of 6–8
animals/group from 1 representative experiment). Ellipses ()) indicate data not
available.
d (group 1 vs. 2 and group 3 vs. 4 and 5, Student’s t test).P ! .05
e (group 3 vs. 4, Mann-Whitney U test).P ! .01
cells. Purified neutrophils (106) were added to 105 conidia that had
been cultured at 377C in 5% CO2 with fetal calf serum for 16–18
h in 96-well flat-bottomed microtiter plates (Costar, Cambridge,
MA), by which time 195% of the conidia had germinated to hyphae
(∼150–200 mm long). After 2 h at 377C with occasional shaking,
the supernatants were aspirated, effector cells were lysed by adding
0.5% sodium deoxycholate, and hyphae viability was determined
by MTT staining. For the conidiocidal activity, 105 conidia were
mixed with 106 purified alveolar macrophages for 4 h in 96-well
flat-bottomed microtiter plates (Costar), and colony-forming units
(cfu) were counted as described elsewhere [17]. The percentage of
cfu inhibition ( ) was determined as follows: % colony-mean 5 SE
formation experimental group/cfu controlinhibition = [100 2 (cfu
.cultures)] 3 100
Flow cytometry. Total lung cells were sequentially reacted with
saturating amounts of phycoerythrin-conjugated anti-CD3 (clone
500A2) and fluorescein isothiocyanate (FITC)–conjugated anti-
CD4 (clone RM4-5), anti-CD8 (clone 53-6.7), anti-abTCR (clone
H57-597), anti-gdTCR (clone GL3), anti-CD44 (clone IM7), anti-
CD45RB (clone 23G2), and anti-CD28 (clone 37.51) MAbs. Total
lung cells or B cells, purified by panning on antiimmunoglobulin-
coated plates, were reacted with saturating amounts of FITC-con-
jugated anti–B7-1 (clone 16-10A1) and anti–B7-2 (clone GL1)
MAbs from PharMingen. Cells were analyzed with a FACScan
flow cytometer (Becton Dickinson, Mountain View, CA) by use of
Cell Quest software (Becton Dickinson) for Macintosh. Nonviable
cells were excluded from analysis by accepted procedures involving
propidium iodide and narrow-forward-angle light-scatter gating.
The percentage of positive phagocytes (mainly neutrophils and
macrophages) was obtained on cells electronically gated by forward
light and scatter analysis, as described elsewhere [34]. The per-
centage of positive cells obtained with an irrelevant antibody was
used as the background value and was always subtracted.
RNA preparation and reverse-transcriptase (RT) polymerase
chain reaction (PCR). Total lung cells were subjected to RNA
extraction by the guanidium thiocyanate–phenol-chloroform pro-
cedure, as described elsewhere [34, 35]. In brief, 5 mg of total RNA
was reverse transcribed into cDNA by use of M-MLV RT (GIBCO
BRL Life Technologies, Gaithersburg, MD). The cDNA was then
amplified with specific primers for murine IL-12 receptor b1 and
b2 (IL-12Rb1 and IL-12Rb2) and hypoxanthine-guanine phos-
phoribosyl transferase (HPRT), the latter as an internal control.
The IL-12Rb1–, IL-12Rb2–, and HPRT–specific primers were the
same as described elsewhere [34].
Amplifications were performed in 2 mM MgCl2, 50 mM KCl,
10 mM Tris-HCl (at pH 8.3), 0.2 mM of each deoxynucleotide
triphosphate, 1 mM of each primer, and 2.5 U of AmpliTaq poly-
merase (Perkin-Elmer Cetus, Norwalk, CT). The cDNA was am-
plified in an automated thermal cycler (Perkin-Elmer Cetus) at 947C
for 60 s, 607C for 60 s, and 727C for 60 s. Amplification was stopped
at 35 cycles. The HPRT primers were used as a control for both
reverse transcription and the PCR reaction and for comparing the
amount of products from samples obtained with the same primers.
The PCR fragments were analyzed by 1.5% agarose gel electro-
phoresis, stained with 0.5 mg/mL ethidium bromide, and visualized
under UV transillumination.
Statistical analysis. Survival data were analyzed by using the
Mann-Whitney U test; significance was defined as . Stu-P ! .01
dent’s t test was used to determine statistical significance between
cytokine production or chitin content; significance was defined as
. In vivo groups consisted of 6–10 animals. Unless otherwiseP ! .05
specified, the data reported were pooled from 3–5 experiments with
similar results. Linear regression analysis was performed using the
DeltaGraph program (SPSS, Chicago).
Results
Course of IPA in IL-42/2 and IL-41/1 mice. To assess the
susceptibility of IL-42/2 and IL-41/1 mice to IPA, mice either
were treated with cyclophosphamide for immunosuppression
or were left untreated before multiple inl administrations of
viable A. fumigatus conidia and were monitored for72 3 10
mortality, fungal growth in lungs, and lung pathology. The
results (table 1) show that the fungal growth in the lungs was
significantly reduced in IL-42/2 compared with wild-type mice,
although both types of mice survived the infection untreated.
When treated with cyclophosphamide, IL-41/1 mice died of the
infection, similar to DBA/2 mice, which are highly susceptible
to IPA [17]. Lung sections revealed the presence of numerous
septate branching hyphae penetrating tissue, with signs of bron-
chial wall damage, peribronchial necrosis, and numerous infil-
trating (predominantly polymorphonuclear) cells (figure 1A),
including eosinophils, which were scattered throughout the lung
parenchyma (E.C., unpublished data). In contrast, cyclophos-
phamide-treated IL-42/2 mice were resistant to infection and
survived. In their lung sections there were few infiltrates (rare
small hyphae with a moderate infiltration of inflammatory
mononuclear and polymorphonuclear cells in the peribronchial
region; figure 1B). No eosinophils were found.
To analyze whether eosinophils were responsible for the lung
Figure 1. Lung histology of (A) immunosuppressed interleukin-4–nondeficient (IL-41/1) and (B) –deficient (IL-42/2) mice with invasive pul-
monary aspergillosis. Giemsa- and periodic acid–Schiff–stained sections were prepared 1 day after last intranasal inoculation of Aspergillus fumigatus
conidia. A, numerous septate branching hyphae penetrate through tissue with signs of bronchial wall damage, peribronchial necrosis, and numerous
infiltrating cells, predominantly polymorphonuclear cells (see inset). mm; 50 mm in inset. B, a few infiltrates and rare small hyphae withBar = 400
moderate infiltration of inflammatory mononuclear cells in peribronchial region. mm; 100 mm in inset.Bar = 400
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Figure 2. Cytokine production by lung lymphocytes (A) and interleukin (IL)–12p70 and IgE levels in bronchiolar lavage (BAL) fluid (B) from
immunosuppressed IL-4–deficient (IL-42/2; solid bars) and –nondeficient (IL-41/1; open bars) mice with invasive pulmonary aspergillosis. Interstitial
lung lymphocytes and BAL fluid were obtained from mice uninfected or 1 day after last intranasal inoculation of Aspergillus fumigatus conidia.
Interstitial lymphocytes were stimulated with anti-CD3 for 48 h. Cytokine and antibody levels were determined by cytokine-specific ELISAs or
by modified antibody-capture bioassay (IL-12p70). Data are of 3–5 separate experiments, each involving replicate measurements.mean 5 SE
!, below assay detection limit. * , IL-42/2 vs. IL-41/1 mice, Student’s t test. IFN, interferon.P ! .05
damage and susceptibility in wild-type mice, we evaluated the
course and outcome of the infection in IL-52/2 mice, which lack
eosinophils [28]. Of interest, IL-52/2 mice were as susceptible
as wild-type mice to the infection (table 1). Histopathologic
examination of lung sections from immunosuppressed IL-52/2
mice revealed patterns of lesions similar to those observed in
IPA and non-IPA [4, 17]. The finding of a massive influx of
neutrophils, but not eosinophils, in highly susceptible IL-52/2
mice (E.C., unpublished data) indicates that neutrophils, rather
than eosinophils, contribute to lung pathology in IL-41/1 mice
with IPA.
Th1 and Th2 cell activation in IL-42/2 and IL-41/1 mice with
IPA. To correlate susceptibility and resistance of IL-41/1 and
IL-42/2 mice to IPA with the activation of Th1 and Th2 cells
in the lungs, we assessed Th cell polarization by measuring Th1
(IFN-g) and Th2 (IL-4, -5, and -10) cytokine production in
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Figure 3. Expression of interleukin (IL)–12R genes in immunosup-
pressed IL-4–deficient (IL-42/2) and –nondeficient (IL-41/1) mice with
invasive pulmonary aspergillosis. Total lung cells from mice uninfected
(lane 1) or 1 day after last intranasal inoculation of Aspergillus fumi-
gatus conidia (lane 2). Cytokine receptor gene expression was assessed
by reverse-transcription polymerase chain reaction (PCR). C, hypo-
xanthine-guanine phosphoribosyl transferase (HPRT)– or cytokine re-
ceptor–specific controls; N, no DNA added to amplification mix during
PCR.
culture supernatants of purified lung interstitial lymphocytes
stimulated with anti-CD3. The levels of IL-12p70 and of total
IgE were also measured in BAL fluid. Lung T cells from
IL-42/2 mice produced (50%–60%) elevated levels of IFN-g,
whereas IL-5 and IL-10 levels were reduced by ∼50% (figure
2A). Further measurement of IL-12p70 in the BAL fluid showed
increased levels in IL-42/2 mice, which, as expected, had low
levels of IgE (figure 2B). This indicates that IL-4 down-regulates
IL-12 production, and consequently Th1 cell development, in
lungs of susceptible BALB/c mice. Of interest, RT-PCR analysis
of the IL-12R showed IL-12Rb2 mRNA expression in inter-
stitial lymphocytes of IL-42/2 mice but not in those of
BALB/c wild-type mice, whereas IL-12Rb1 mRNA was ex-
pressed at similar levels by both types of mice (figure 3). It has
been suggested that expression of the IL-12Rb2 chain may be
down-regulated during Th2 cell development in BALB/c mice
[36].
Next we assessed the role of Th1 responses during IPA and
whether IL-42/2 mice develop resistance because of the aug-
mented IL-12 levels and ensuing Th1 responses. To this end,
A. fumigatus infection was evaluated in IL-12p402/2 and
IFN-g2/2 mice and in BALB/c wild-type and IL-42/2 mice
treated with IL-12 neutralizing antibody. Measurement of the
chitin content in lungs, which correlates with fungus burden,
showed that susceptible BALB/c mice became even more sus-
ceptible in the absence of IL-12 (by neutralization or by genetic
disruption) and IFN-g (figure 4A). Moreover, IL-42/2 mice
treated with antibody to IL-12 developed susceptibility similar
to that of IL-122/2 and IFN-g2/2 mice (figure 4A).
We next asked whether antifungal effector cells of IL-42/2
mice possess elevated activity. The results show that, soon after
infection, the conidiocidal activity of macrophages does not
differ between resistant IL-42/2 and susceptible wild-type
BALB/c mice (figure 4B). In contrast, hyphal damage of neu-
trophils was increased by 180% in IL-42/2 compared with wild-
type mice (figure 4B). Together, these results suggest that the
resistance of IL-42/2 mice to IPA is mediated by elevated type
1 responses.
Costimulation dependency of Th cell activation in mice with
IPA. To determine the contribution of the B7-1 and B7-2
costimulatory molecules in the development of antifungal Th
responses, we evaluated the expression of these molecules in
the lungs of mice upon infection and assessed the effects of
their neutralization on Th cell polarization and the outcome of
infection. Figure 5 shows that both molecules were expressed
on B cells and phagocytic cells in IL-41/1 and, to a lesser extent,
in IL-42/2 mice. Local treatment of BALB/c mice with anti–B7-
1 MAb alone or with a combination of anti–B7-1 and anti–B7-
2 MAbs greatly decreased fungus burden in the lung and con-
comitantly resulted in high-level production of IL-12 and
IFN-g, whereas IL-4 and IL-10 production was unaltered (table
2). Similar results were obtained by treatment with the CTLA-
4 Ig molecule, which neutralizes B7-1 and B7-2 (E.C., unpub-
lished data). In contrast, treatment of BALB/c mice with
anti–B7-2 MAb alone resulted in impaired production of IL-4
and IL-10, while leaving IL-12 and IFN-g levels unaltered (ta-
ble 2). Of interest, fungus burden was slightly increased rather
than decreased, despite reduced Th2 responses, a finding sug-
gesting that the extent of fungal growth correlates with levels
of Th1 rather than levels of Th2 immune reactivity. Similar
results were obtained with antibody treatment of IL-42/2 mice
(table 2). Anti–B7-1 MAb alone or a combination of anti–B7-
1 and anti–B7-2 MAbs further increased type 1 cytokine (IL-
12 and IFN-g) production, which was already increased in these
mice because of the absence of IL-4. As a result, fungus burden
became even more reduced in resistant IL-42/2 mice. In contrast,
anti–B7-2 treatment did not further decrease Th2 cytokine pro-
duction (IL-10), which was already low due to the absence of
IL-4. Together, these results strongly suggest that fungus burden
correlates well with the intensity of type 1 but not type 2 re-
sponses and that IL-42/2 mice became resistant to IPA because
of increased Th1 development rather than decreased Th2 de-
velopment. Figure 6 shows a regression analysis of cytokine
production (IL-12, IFN-g, and IL-10) versus fungus burden
(i.e., chitin content), which supports this conclusion from ex-
perimental findings.
Discussion
This study was undertaken to identify the precise mecha-
nism(s) through which IL-4 exerts its pathogenetic role in mice
with IPA. IL-42/2 mice were highly resistant to IPA compared
with wild-type mice. Resistance was associated with decreased
lung inflammatory pathology and fungal growth and local oc-
currence of IL-12–dependent, IFN-g–producing Th1 cells. The
results demonstrate that IL-4 is responsible for the suppression
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Figure 4. Invasive pulmonary aspergillosis (IPA) course in immunosuppressed BALB/c wild-type and interleukin-4–deficient (IL-42/2) mice
upon IL-12 neutralization and in IL-12p402/2 and interferon-g–deficient (IFN-g2/2) mice. A, for IL-12 neutralization, 500 mg of sheep anti–IL-
12 antibody was given intraperitoneally 4 h before fungal inoculation. Fungal colonization in lung was determined 1 day after last intranasal
(inl) inoculation of Aspergillus fumigatus conidia and is expressed as mg of glucosamine/organ (chitin content). B, conidiocidal activity and hyphal
damage of purified macrophages and neutrophils, respectively, from IL-42/2 or IL-4–nondeficient (IL-41/1) mice with IPA. Conidiocidal activity
and hyphal damage from uninfected IL-42/2 and IL-41/1 mice, expressed as %, were as follows: vs. and vs. . Assays22 5 2 18 5 3 25 5 2 18 5 4
were done as described in Materials and Methods 1 day after last inl inoculation of A. fumigatus conidia. Values are of 3–5 experiments.mean 5 SE
* , treated vs. untreated mice and mutant vs. wild-type mice, Student’s t test.P ! .05
of protective Th1 cell responses, a finding in line with the cu-
rative effect observed on IL-4 inhibition in IL-41/1 mice [17,
30, 37].
The recruitment and activation of inflammatory cells in the
setting of pathogen challenge is a complex and dynamic process
that involves the coordinated expression of both pro- and anti-
inflammatory mediators, such as chemokines and cytokines [38,
39]. Indeed, although an inflammatory response is essential to
clear pathogens from the site of infection, a prolonged inflam-
matory response might worsen lung injury and interfere with
pathogen elimination [40].
We found that, although the absolute numbers of cells re-
cruited into the lungs were not different in IL-42/2 and IL-41/1
mice upon infection (E.C., unpublished data), the overall in-
flammatory response was mitigated in the absence of IL-4, as
judged by the reduced number of inflammatory cells at the
lesion sites. These results are not consistent with the anti-in-
flammatory activity of IL-4 in the lungs, which includes re-
duction of neutrophil recruitment and of synthesis of IL-8 [41].
However, in addition to its role in promoting IgE immediate-
type hypersensitivity [19], IL-4 also has proinflammatory effects
in fungal infections, such as enhancement of macrophage man-
nose receptor activity [42], stimulation of phagocytosis and kill-
ing of yeast cells [43, 44], and priming of neutrophils for IL-
12 production [45]. Therefore, the effect IL-4 may have in the
inflammatory lung response to fungi may be complex and may
result from multiple activities. In fact, the decreased lung in-
flammatory response observed in IL-42/2 mice with IPA is at
variance with that observed in IL-42/2 mice with ABPA [46–48].
In this model, no differences were observed in lung injury be-
tween IL-42/2 and IL-41/1 mice upon sensitization to A. fu-
migatus antigen, despite a characteristic Th1 response. Thus,
IL-4 has a nonessential role in the development of lung injury
during the allergic response to the fungus [46–48]. Moreover,
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Figure 5. Expression of B7-1 and B7-2 costimulatory molecules in lungs of interleukin-4–deficient (IL-42/2) and –nondeficient (IL-41/1) mice
with invasive pulmonary aspergillosis. Purified B (A) or total lung (B) cells recovered 1 day after last fungal challenge were stained with fluorescein
isothiocyanate–conjugated anti–B7-1 or anti–B7-2 monoclonal antibodies (MAbs; open histogram) or irrelevant MAb (black histogram). Phagocytic
cells were electronically gated by forward light and side scatter analysis.
although eosinophils were differentially recruited in the lungs
of IL-42/2 and IL-41/1 mice upon infection, the finding that the
inflammatory response and course of infection were not im-
proved in IL-52/2 mice suggests a minimal role, if any, for eo-
sinophils in the pathogenesis of IPA. These data indicate that
cellular and molecular players of inflammation may have dif-
ferent roles in the pathogenesis of allergic and nonallergic lung
diseases caused by A. fumigatus. In the case of invasive asper-
gillosis, neutrophils appear to be an important mediator of
antifungal inflammatory and immune responses, a finding in
line with that observed in candidiasis [49].
IL-4 has a pivotal role in CD4 Th2 differentiation in both
allergic [19, 50] and nonallergic [17, 30, 37] diseases caused by
A. fumigatus. IgE production was absent in IL-42/2 mice with
ABPA [46], and IL-4 neutralization increased Th1-dependent
protective immunity in mice with aspergillosis [17, 30, 37]. We
found that susceptibility of IL-41/1 mice to IPA was associated
with the activation of Th2 lymphocytes producing IL-4, IL-5,
and IL-10 and with the production of IgE. In contrast, resis-
tance of IL-42/2 mice to infection was associated with the pro-
duction of IL-12 and the activation of interstitial T lymphocytes
producing IFN-g and responsive to IL-12. We recently reported
that, in addition to IL-12 production, responsiveness to IL-12
is a prerequisite for Th1 cell development in mice with Candida
albicans infections [51]. Similar conditions appear to be required
for the generation of Th1 cell reactivity to A. fumigatus, as Th1-
mediated resistance was impaired in IL-42/2 mice upon IL-12
neutralization and in IL-122/2 mice. Moreover, lung lympho-
cytes from IL-42/2, but not IL-41/1, mice expressed functional
IL-12 receptor.
The finding that resistance to infection is impaired in
IFN-g2/2 mice indicates the important role this cytokine may
have in the control of A. fumigatus infection. In addition to its
role in regulating the generation of antifungal Th1 cells [35],
IFN-g potentiates the oxidative responses and hyphal damage
of human phagocytic cells [52], as observed in patients with
chronic granulomatous disease treated with IFN-g [53]. These
observations are in line with our finding of the increased an-
tifungal activity of neutrophils in infected IL-42/2 mice. Against
Aspergillus species, Th1 (IFN-g and TNF-a) and Th2 (IL-4
and IL-10) cytokines have opposite effects on phagocytic host
defenses [5]. IL-10, more than IL-4, has a suppressive effect on
the antifungal activity of mononuclear cells against the fungus
[5]. It has been suggested that IL-10 may have a pathogenetic
role in the chronic form of pulmonary aspergillosis that is in-
dependent of neutropenia and corticosteroid therapy [12, 14].
We previously showed that IL-10 inhibition early in infection
ameliorates the course of IPA in highly susceptible mice [17].
In the present study, we found that IL-10 was produced in IL-
41/1 mice upon infection and was elevated in conditions of
increased susceptibility to the infection, such as those observed
in IL-122/2 or IFN-g2/2 mice or in IL-42/2 mice upon IL-12
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Table 2. Effect of B7-1 and B7-2 neutralization on fungal growth
and cytokine production in interleukin (IL)–41/1 and IL-42/2 mice with
invasive pulmonary aspergillosis.
Mice and
treatmenta
Chitin
contentb
Cytokinec
IL-12p70 IFN-g IL-4 IL-10
IL-41/1
Neither 29 5 2.7 5 5 2 14 5 3 44 5 3 61 5 4
Anti–B7-1 14 5 3.0d 24 5 3d 84 5 4d 55 5 6 50 5 6
Anti–B7-2 39 5 4.1d 7 5 1 17 5 2 18 5 2d 26 5 5d
Both 18 5 2.1d 21 5 2d 71 5 3d 37 5 5 47 5 3
IL-42/2
Neither 13 5 3.5 18 5 2 68 5 5 !0.5 18 5 4
Anti–B7-1 7 5 0.5d 28 5 4d 110 5 6d !0.5 21 5 5
Anti–B7-2 20 5 3.3 22 5 4 58 5 4 !0.5 14 5 3
Both 9 5 1.7d 32 5 3d 98 5 3d !0.5 16 5 2
NOTE. IL-41/1, IL-4 nondeficient; IL-42/2, IL-4 deficient; IFN, interferon.
a Mice were treated with anti–B7-1 and/or anti–B7-2 monoclonal antibody
(given intranasally [inl] at 100 mg/50 mL) 4 h before Aspergillus fumigatus injection.
b Chitin content in lungs, expressed as mg of glucosamine/organ, was deter-
mined 3 days after last fungal inl inoculation. Values are mean 5 SE of 3–5
separate experiments.
c Cytokine levels (ng/mL) in bronchoalveolar lavage fluid (IL-12p70) or in
culture supernatants of anti-CD3–stimulated lung T cells were determined 3 days
after last fungal inoculation. Values are mean 5 SE of 3–5 separate experiments,
each involving replicate measurements. !0.5, below assay detection limit.
d (treated vs. untreated mice, Student’s t test).P ! .05
Figure 6. Correlation of fungal load with T helper (Th) 1 (interleukin [IL]–12p70 and interferon [IFN]–g) but not Th2 (IL-10) cytokine
production in mice with invasive pulmonary aspergillosis. Regression analysis was performed by plotting values of chitin content (mg of glucosamine/
organ) as function of IL-12p70 (A), IFN-g (B), or IL-10 (C) production. Data are from table 2. Linear regression analysis showed correlation
coefficients (r2) of .78, .88, and .62 (A–C, respectively).
neutralization (E.C., unpublished data). However, these results,
although suggestive of a detrimental effect of IL-10 in mice
with IPA, do not allow us to predict its precise role in infection,
given the potentially complex role of IL-10 in the pathogenesis
of lung pathology and infections [26, 38, 54–56].
The mechanisms underlying the activation of Th cells in the
lungs of mice with IPA are not yet defined. The type of Th cell
responses to antigens encountered on the mucosal surfaces of
the respiratory tract may be influenced by regional environ-
mental factors, such as the nature of regional innate immunity
[57] and the expression of costimulatory molecules [58–60]. On
looking at the expression of B7-1 and B7-2 molecules in the
lungs of IL-41/1 and IL-42/2 mice upon infection, we found an
increased expression of both costimulatory molecules in the
lungs of IL-41/1 mice. In contrast, the expression of B7-1 and
B7-2, in particular, was low in IL-42/2 mice, consistent with the
finding that IL-4 can induce expression of both costimulatory
molecules on B cells [61]. More importantly, blockade of either
of the costimulatory molecules had a different effect on fungus
burden and pattern of Th cytokine production in either type
of mice. B7-1 neutralization was followed by decreased fungal
growth and elevated production of both IL-12 and IFN-g,
whereas levels of IL-4 and IL-10 were not substantially mod-
ified. In contrast, B7-2 neutralization appeared to reduce Th2
cytokine production without affecting that of IL-12 and
IFN-g. This pattern of cytokine production is consistent with
the results obtained on fungal growth. Indeed, cytokines with
activating signals for fungicidal effector cells were increased
upon B7-1 neutralization. In contrast, cytokines with deacti-
vating signals were down-regulated upon B7-2 neutralization,
but, as a result of B7-1 engagement, cytokines with activating
signals were not increased. This finding may explain why the
fungal growth was not decreased in these mice. In fact, the
fungal growth was somewhat increased upon B7-2 neutrali-
zation, particularly in IL-41/1 mice.
Whether B7-2 has an effect on fungal growth beyond its
costimulatory activity remains to be determined. The finding
that simultaneous blockade of both molecules led to effects
similar to those obtained upon B7-1 blockade indicates a dom-
inant role of B7-1 over B7-2 in the development of antifungal
immunity in mice with IPA. In particular, as no evidence of
immune deviation was observed during each treatment, it ap-
pears that each costimulatory molecule may have a distinct,
nonoverlapping role in the antifungal immune response in vivo.
Because IL-12 and IFN-g production were increased upon B7-
1 neutralization, the engagement of the B7-1 molecule appears
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to result in an inhibitory signal for IL-12 and IFN-g produc-
tion. That B7-1 may provide both a costimulatory and a down-
regulatory signal during the course of an immune response has
been reported [62, 63]. In our study, the blockade of the CTLA-
4 inhibitory coreceptor also resulted in the activation of the IL-
12– and IFN-g–dependent pathway (data not shown), thus
strongly indicating that the down-regulatory signal delivered
by B7-1 may occur through its engagement with the CTLA-4
coreceptor, as reported [64]. Although studies in CTLA-4– or
CD28-deficient mice will definitively clarify this issue, it appears
that one important role of B7-1 in the activation of B7-2–de-
pendent Th2 antifungal responses is the concomitant inhibition
of IL-12–dependent Th1 reactivity. This would corroborate the
suggestion that the amount of T cell costimulatory signals in
the form of B7-2 in nonlymphoid tissues may be limiting, lead-
ing to the need for further signaling provided by B7-1 [65].
Our findings would help to explain some still controversial
results on the role of costimulatory molecules in the develop-
ment of lung mucosal immunity. It is well documented that the
induction of CD4 Th2 reactivity to aeroallergens is strictly de-
pendent on B7-2, but not B7-1, costimulatory molecules [58,
59]. However, in infection with Bordetella pertussis, hypore-
sponsiveness of lung T cells is associated with a biased ex-
pression of B7-1 in relation to B7-2 [60]. These results parallel
those obtained in infection by the nematode parasite Helig-
mosomoides polygyrus, in which blockade of both costimulatory
molecules was required to inhibit the parasite-specific Th2 im-
mune response [66, 67]. Thus, it is clear that the requirement
for costimulatory molecules during immune responses is quite
complex and likely depends on a number of factors unique to
each specific type of immune response. In particular, the role
of costimulation may vary in the different lymphoid micro-
environments, paradoxes being observed in antigen-specific mu-
cosal and systemic immune responses in CTLA4-Hg1 trans-
genic mice [65].
All together, the results of the present study suggest a possible
scenario of IL-4 regulation of costimulation-dependent Th im-
munity in mice with IPA. In addition to its growth-promoting
activity on Th2 cells, IL-4 appears to be required, although not
essential, for local expression of both costimulatory molecules,
whose engagement results in up-regulation of IL-4 and IL-10
and concomitant down-regulation of IFN-g and IL-12. This
would predict that, in conditions of functional IL-4 deficiency,
the defective expression of both molecules will further contrib-
ute to the decreased production of Th2 cytokines, such as IL-
10, while increasing that of IFN-g and IL-12. It appears that
the balance between Th1 and Th2 cells in mice with IPA is
determined by many induction pathways and that costimula-
tion and promotion of Th2 cell growth are successfully con-
trolled by IL-4. Experiments in which exogenous IL-4 is given
to IL-42/2 mice will clarify this issue.
In conclusion, our results demonstrate that IL-42/2 mice are
resistant to IPA and its pathology through the induction of
protective Th1 responses and that the induction of lung effector
Th2 responses in allergy and infection may occur through dis-
tinct costimulatory pathways. IL-4 appears to be responsible
for the inhibition of Th1 cell development and for the gener-
ation of Th2 cell responses. However, Th2 effector mechanisms
(including eosinophils) per se do not critically increase suscep-
tibility to the infection, a finding in line with the observation
that atopy is a predisposing factor for developing ABPA [50]
but not invasive aspergillosis [4] in humans. Because mortality
with invasive aspergillosis is very high, the present study is an
effort to better understand host defenses against A. fumigatus,
with the ultimate goal of improving management of an infection
with such a dismal outcome.
Acknowledgments
We thank Stefano Temperoni and Alessandro Braganti, University
of Perugia animal facility, for technical assistance.
References
1. Rhodes JC. Aspergillosis. In: Murphy JW, Friedman H, Bendinelli M, eds.
Fungal infections and immune responses. New York: Plenum Press, 1993:
359–77.
2. Saral R. Candida and Aspergillus infections in immunocompromised patients:
an overview. Rev Infect Dis 1991;13:487–92.
3. Binder RE, Faling LJ, Pugatch RD, Mahasen C, Snider GL. Chronic nec-
rotizing pulmonary aspergillosis: a discrete clinical entity. Medicine
1982;61:109–24.
4. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781–805.
5. Roilides E, Katsifa H, Walsh TJ. Pulmonary host defences against Aspergillus
fumigatus. Res Immunol 1998;149:454–65.
6. Schaffner A, Douglas H, Braude A. Selective protection against conidia by
mononuclear and against mycelia by polymorphonuclear phagocytes in
resistance to Aspergillus: observations on these two lines of defense in
vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982;69:
617–31.
7. Cohen MS, Isturiz RE, Malech HL, et al. Fungal infection in chronic gran-
ulomatous disease: the importance of the phagocytes in defense against
fungi. Am J Med 1981;71:59–66.
8. Morgenstern DE, Gifford MAC, Li LL, Doerschuk CM, Dinauer MC. Ab-
sence of respiratory burst in X-linked chronic granulomatous disease mice
leads to abnormalities in both host defense and inflammatory response
to Aspergillus fumigatus. J Exp Med 1997;185:207–18.
9. Schnaffer A. Therapeutic concentrations of glucocorticoids suppress the an-
timicrobial activity of human macrophages without impairing their re-
sponsiveness to gamma interferon. J Clin Invest 1985;76:1755–64.
10. Palmer LB, Greenberg HE, Schiff M. Corticosteroid treatment as a risk factor
for invasive aspergillosis in patients with lung disease. Thorax 1991;46:
15–20.
11. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Pro-
longed granulocytopenia: the major risk factor for invasive pulmonary
aspergillosis in patients with acute leukemia. Ann Intern Med 1984;100:
345–51.
12. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA.
Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N
Engl J Med 1991;324:654–62.
13. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Impairment of neu-
trophil antifungal activity against hyphae of Aspergillus fumigatus in chil-
JID 1999;180 (December) Aspergillosis in IL-4 Knockout Mice 1967
dren infected with human immunodeficiency virus. J Infect Dis 1993;167:
905–11.
14. Roilides E, Dimitriadou A, Kadiltsoglou I, et al. IL-10 exerts suppressive
and enhancing effects on antifungal activity of mononuclear phagocytes
against Aspergillus fumigatus. J Immunol 1997;158:322–9.
15. Grazziutti ML, Rex JH, Cowart RE, Anaissie EJ, Ford A, Savary CA.
Aspergillus fumigatus conidia induce a Th1-type cytokine response. J Infect
Dis 1997;176:1579–83.
16. Wolach B, Alon E, Gottesman G, Yellin A. Pulmonary aspergillosis in a child
with hyperimmunoglobulin E syndrome. Clin Infect Dis 1998;26:204–5.
17. Cenci E, Mencacci A, Fe` d’Ostiani C, et al. Cytokine- and T helper–dependent
lung mucosal immunity in mice with invasive pulmonary aspergillosis. J
Infect Dis 1998;178:1750–60.
18. Romani L. The T cell response against fungal infections. Curr Opin Immunol
1997;9:484–90.
19. Ryan JJ. Interleukin-4 and its receptor: essential mediators of the allergic
response. J Allergy Clin Immunol 1997;99:1–5.
20. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5
deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage
in a mouse asthma model. J Exp Med 1996;183:195–201.
21. Corry DB, Folkesson HG, Warnock ML, et al. Interleukin 4, but not inter-
leukin 5 or eosinophils, is required in a murine model of acute airway
hyperreactivity. J Exp Med 1996;183:109–17.
22. Horgan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS. Aeroallergen-
induced eosinophilic inflammation, lung damage, and airways hyperreac-
tivity in mice can occur independently of IL-4 and allergen-specific im-
munoglobulins. J Clin Invest 1997;99:1329–39.
23. Kurup VP, Mauze S, Choi S, Seymour BW, Coffman RB. A murine model
of allergic bronchopulmonary aspergillosis with elevated eosinophils and
IgE. J Immunol 1992;148:3783–8.
24. Knutsen AP, Mueller KR, Levine AD, Choulan B, Hutcheson PS, Slavin
RG. AspfI CD41 Th2-like T-cell lines in allergic bronchopulmonary as-
pergillosis. J Allergy Clin Immunol 1994;94:215–21.
25. Crameri R, Faith A, Hemmann S, et al. Humoral and cell-mediated auto-
immunity in allergy to Aspergillus fumigatus. J Exp Med 1996;184:265–70.
26. Gru¨nig G, Corry DB, Leach MV, Seymour BWP, Kurup VP, Rennick BM.
Interleukin-10 is a natural suppressor of cytokine production and inflam-
mation in a murine model of allergic bronchopulmonary aspergillosis. J
Exp Med 1997;185:1089–99.
27. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler
G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses.
Nature 1993;362:245–8.
28. Kopf M, Brombacher F, Hodgkin PD, et al. IL-5 deficient mice have a
developmental defect in CD51 B-1 cells and lack eosinophilia but have
normal antibody and cytotoxic T cell responses. Immunity 1996;4:15-24.
29. Dalton DK, Pitts MS, Keshaw S, Figari IS, Bradley A, Stewart TA. Multiple
defects of immune cell function in mice with disrupted interferon-gamma
genes. Science 1993;259:1739–42.
30. Cenci E, Perito S, Enssle KH, et al. Th1 and Th2 cytokines in mice with
invasive aspergillosis. Infect Immun 1997;65:564–70.
31. Razi-Wolf Z, Galvin F, Gary G, Reiser H. Evidence for an additional ligand,
distinct from B7, for the CTLA-4 receptor. Proc Natl Acad Sci USA
1993;90:11182–6.
32. Hathcock KS, Laszlo G, Dickler HB, Bradshaw J, Linsley P, Hodes RJ.
Identification of an alternative CTLA-4 ligand costimulatory for T cell
activation. Science 1993;262:905–7.
33. Romani L, Mencacci A, Cenci E, Del Sero G, Bistoni F, Puccetti P. An
immunoregulatory role for neutrophils in CD41 T helper subset selection
in mice with candidiasis. J Immunol 1997;158:2356–62.
34. Mencacci A, Cenci E, Del Sero G, et al. Defective costimulation and impaired
Th1 development in TNF/LT-a-double deficient mice infected with Can-
dida albicans. Int Immunol 1998;10:37–48.
35. Cenci E, Mencacci A, Del Sero G, et al. IFN-g is required for IL-12 re-
sponsiveness in mice with Candida albicans. J Immunol 1998;161:3543–50.
36. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin
(IL)-12Rb2 subunit expression in developing T helper 1 (Th1) and Th2
cells. J Exp Med 1997;185:817–24.
37. Cenci E, Mencacci A, Fe` d’Ostiani C, et al. Cytokine- and T-helper–
dependent immunity in murine aspergillosis. Res Immunol 1998;149:
445–54.
38. Huffnagle GB, Lipscomb MF. Cells and cytokines in pulmonary cryptococ-
cosis. Res Immunol 1998;149:387–96.
39. Kolls JK, Nelson S, Summer WR. Recombinant cytokines and pulmonary
host defense. Am J Med Sci 1993;306:330–5.
40. Smith JA. Neutrophils, host defense, and inflammation: a double-edged
sword. J Leukoc Biol 1994;56:672–86.
41. Wertheim WA, Kunkel SL, Standiford TJ, et al. Regulation of neutrophil-
derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J
Immunol 1993;151:2166–75.
42. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances
murine macrophage mannose receptor activity: a marker of alternative
immunologic macrophage activation. J Exp Med 1992;176:287–92.
43. Redmond H, Schuchter L, Shou R, et al. Interleukin 4 (IL-4) enhances mac-
rophage microbicidal function. J Leukoc Biol 1990;48(suppl):24.
44. Bobert LA, Waters TA, Pugliese-Sivo CC, Sullivan LM, Narula SK, Grace
MJ. IL-4 induces neutrophilic maturation of HL-60 cells and activation
of human peripheral blood neutrophils. Clin Exp Immunol 1995;99:
129–36.
45. Mencacci A, Del Sero G, Cenci E, et al. IL-4 is required for development
of protective CD41 T helper type 1 cell responses to Candida albicans. J
Exp Med 1998;187:307–17.
46. Kurup VP, Guo J, Murali PS, Choi H, Fink JN. Immunopathologic responses
to Aspergillus antigen in IL-4 knockout mice. J Lab Clin Med 1997;130:
567–75.
47. Kurup VP, Choi HY, Murali PS, Xia JQ, Coffman RL, Fink JN. Immune
responses to Aspergillus antigen in IL-42/2 mice and the effect of eosinophil
ablation. Allergy 1999;54:420–7.
48. Kurup VP, Xia JQ, Rickaby BA, Dawson CA, Choi H, Fink JN. Aspergillus
fumigatus antigen exposure results in pulmonary lung airway resistance
in wild-type but not in IL-4 knockout mice. Clin Immunol 1999;90:
404–10.
49. Romani L, Bistoni F, Puccetti P. Initiation of T-helper cell immunity to
Candida albicans: the role of neutrophils. Chem Immunol 1997;68:110–35.
50. Kurup VP, Grunig G, Knutsen AP, Murali PS. Cytokines in allergic bron-
chopulmonary aspergillosis. Res Immunol 1998;149:466–77.
51. Mencacci A, Cenci E, Bistoni F, et al. Specific and nonspecific immunity to
Candida albicans: a lesson from genetically modified animals. Res Im-
munol 1998;149:352–61.
52. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Enhancement of oxi-
dative response and damage caused by human neutrophils to Aspergillus
fumigatus hyphae by granulocyte colony-stimulating factor and gamma
interferon. Infect Immun 1993;61:1185–93.
53. Rex JH, Bennet JE, Gallin JI, Malech HL, DeCarlo ES, Melnick DA. In
vivo interferon-g therapy augments the in vitro ability of chronic gran-
ulomatous disease neutrophils to damage Aspergillus hyphae. J Infect Dis
1991;163:849–52.
54. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE,
Standiford TJ. Neutralization of IL-10 increases survival in a murine
model of Klebsiella pneumonia. J Immunol 1995;155:722–9.
55. Sawa T, Corry DB, Gropper MA, Ohara M, Kurahashi K, Wiener-Kronish
JP. IL-10 improves lung injury and survival in Pseudomonas aeruginosa
pneumonia. J Immunol 1997;159:2858–66.
56. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. IL-10
impairs host defense in murine pneumococcal pneumonia. J Infect Dis
1996;174:994–1000.
57. Lin JY, Wang Li F, Lin RH. The association between lung innate immunity
and differential airway antigen-specific immune responses. Int Immunol
1996;8(4):499–507.
1968 Cenci et al. JID 1999;180 (December)
58. Tsuyuki S, Tsuyuki J, Einsle K, Kopf M, Coyle AJ. Costimulation through
B7-2 (CD86) is required for the induction of a lung mucosal T helper cell
2 (Th2) immune response and altered airway responsiveness. J Exp Med
1997;185:1671–9.
59. Keane-Myers A, Gause WC, Linsley PS, Chen SJ, Wills-Karp M. B7-CD28/
CTLA-4 costimulatory pathways are required for the development of T
helper cell 2-mediated allergic airway responses to inhaled antigens. J
Immunol 1997;158:2042–9.
60. McGuirk P, Mahon BP, Griffin F, Mills KHG. Compartmentalization of T
cell responses following respiratory infection with Bordetella pertussis:
hyporesponsiveness of lung T cells is associated with modulated expression
of the co-stimulatory molecule CD28. Eur J Immunol 1998;28:153–63.
61. Stack RM, Lenschow DJ, Gray GS, Bluestone JA, Fitch FW. IL-4 treatment
of small splenic B cells induces costimulatory molecules B7-1 and B7-2.
J Immunol 1994;152:5723–33.
62. Sethna MP, Parijs LW, Sharpe AH, Abbas AK, Freeman GJ. A negative
regulatory function of B7 revealed in B7-1 transgenic mice. Immunity
1994;1:415–21.
63. Gause CW, Halvorson MJ, Lu P, et al. The function of costimulatory mol-
ecules and the development of IL-4–producing T cells. Immunol Today
1997;18:115–20.
64. Fallarino F, Fields PE, Gajewski TF. B7-1 engagement of cytotoxic T lym-
phocyte antigen 4 inhibits T cell activation in the absence of CD28. J Exp
Med 1998;188:205–10.
65. Ga¨rdby E, Lane P, Lycke NY. Requirements for B7-CD28 costimulation in
mucosal IgA responses: paradoxes observed in CTLA4-Hg1 transgenic
mice. J Immunol 1998;161:49–59.
66. Greenwald RJ, Lu P, Halvorson MJ, et al. Effects of blocking B7-1 and B7-
2 interactions during a type 2 in vivo immune response. J Immunol
1997;158:4088–96.
67. Subramanian G, Katzura JW, Pearlman E, Jia X, Malhotra I, King CL. B7-
2 requirement for helminth-induced granuloma formation and CD4 type
2 helper cell cytokine expression. J Immunol 1997;158:5914–20.
